Professional Documents
Culture Documents
EXPERIMENTATION
WITH DRUGS
1
Why?
An animal may react to a chemical in a way different from the reaction
of a human being. Also, the possible side-effects of a drug are to be
ascertained before it can be allowed to be made available to patients.
A chemical that is safe for animals may produce serious side-effects
when administered to a human being.
Presentation title 2
Likewise, in vitro studies, that is, studies conducted outside the human
body, as for instance, in a test-tube or a culture-dish, also do not
guarantee that the same effects will occur when that drug or chemical is
actually administered to a patient.
Presentation title 3
EXPERIMENTATION ON HUMAN IS NECESSARY
1 2 3 4 5
To use a new To conduct To find out To find out the To study the
drug for a medical research whether a drug possible side- optimum
therapeutic to study the effects is safe for effects of a drug dosage of a
purpose. - To of certain drugs on human drug, that is,
find out, for human beings, so consumption. A how much of it
instance, if a that a conclusion drug that is can be given in
drug is effective may be arrived at found to be safe one dose, how
in a particular regarding the in trials on many doses can
efficacy of that
illness, where drug
animals may be given in one
other drugs produce adverse day and how
have failed to effects when long a patient
cure that illness. administered to can continue the
humans. use of that drug.
4
CLINICAL TRIAL
Presentation title 5
CLINICAL TRIAL PROCEDURE
1. 2
FULL INFORMED CONCENT
FULL INFORMATION GIVEN
ABOUT THE EXPERIMENT
3
OF ALL THE PARTICIPANTS Attention is to be drawn to
possible alternative.
5
4 •The schedules of tests and
.If the clinical study procedures
involves a pregnant •The drugs involved
woman, extra care and •The dosages, or amount of
protective measures are the drug
called for to safeguard the 6
woman and her child.
Ethics Committee
Presentation title 9
National Ethical Guidelines for Biomedical Research
Involving Children
1.inclusion of Children in Research:
1. It is crucial to include children in clinical research, including clinical trials. By doing so, the benefits of new
therapies can be applied to children promptly.
2. Traditionally, children have often been the last to benefit from medical advancements. However, due to their
inherent vulnerability, potential risks from participating in research studies must be anticipated, and adequate
precautions should be taken.
2.Unique Considerations for Research Involving Children:
1. Research involving children should consider their unique physiology, anatomy, psychology, pharmacology,
social situation, and special needs, as well as those of their families.
2. A child-friendly environment should be maintained during research whenever possible.
3.Risk Assessment:
1. Researchers must assess the benefit and risk of research involving children.
2. Risks should be classified, considering factors such as minimal risk and more than minimal risk.
4.Safety and Efficacy of Drugs:
1. Before testing drugs in children, safety, pharmacokinetics, and initial indications of efficacy should be
established in adults.
2. Drugs should be tested for safety and efficacy in children after initial adult studies.
10
THANKYOU.